Close
Nordic 9Nordic 9

Baliopharm (investor - Corporate Investor)

Switzerland
See something wrong or missing? Let us know

Baliopharn is a Swiss biotech company.

Average round investment:400k USD
Average number per year:1.0
Distribution: 2016 (1)
Portfolio companies: Iceland 3Z Pharmaceuticals
Mostly invests in: Iceland Iceland (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Baliopharm

Name Criteria
Iceland Sigþór Sigmarsson
62%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.0
Iceland Lífsverk
62%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.0
Probiocon
62%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.0
Sweden Västkusten Affärsänglar
57%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.5
Sweden Eva Redhe
56%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.5
Sweden Mattias Weinhandl
52%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 4.5
Denmark Startupbootcamp
51%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Iceland
  • Average number of deals per year: 1.2
Spain CECOP
48%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden Maximilian Hermelin
48%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Denmark Michael Krogh
48%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Top